Jin Medical International
ZJYL
ZJYL was delisted on the 31st of July, 2026.
6 hedge funds and large institutions have $1.81M invested in Jin Medical International in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
761% more capital invested
Capital invested by funds: $210K → $1.81M (+$1.6M)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
0.02% less ownership
Funds ownership: 0.12% → 0.09% (-0.02%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$181K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$42.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$18.6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$373 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$203K |
| 2 |
JP Morgan Chase
New York
|
-$3.93K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $1.32M | +$181K | +5,327 | New |
|
|
XT
2
XTX Topco
George Town,
Cayman Islands
| $312K | +$42.6K | +1,257 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $136K | +$18.6K | +548 | New |
|
|
4
JP Morgan Chase
New York
| $38.9K | -$3.93K | -116 | -42% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $2.73K | +$373 | +11 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1.74K | -$1.22K | -36 | -84% |
|
|
VF
7
Virtu Financial
New York
| – | -$203K | -8,663 | Closed |
|
ZJYL Hedge Fund Activity: Q4 2023 in Review
6 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q4 2023, worth a combined $1.81M — up 761% from $210K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ZJYL positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $181K. The largest seller was Virtu Financial, exiting entirely with an estimated $203K sold.
- 6 institutional investors held Jin Medical International (ZJYL) as of Q4 2023, up from 3 in Q3 2023.
- Funds reported $1.81M of Jin Medical International stock for Q4 2023, up 761% quarter-over-quarter.
- 4 funds opened new Jin Medical International positions in Q4 2023 and 1 closed out, a net change of +3 holders.
- The largest Jin Medical International buyer in Q4 2023 was Geode Capital Management, an estimated $181K added.
- The largest Jin Medical International seller in Q4 2023 was Virtu Financial, an estimated $203K sold.
Based on aggregated 13F filings for Q4 2023.